RG7769 (PD1-TIM3), a Novel Heterodimeric Avidity-Driven T Cell Specific PD-1/TIM-3 Bispecific Antibody Lacking Fc-mediated Effector Functions for Dual Checkpoint Inhibition to Reactivate Dysfunctional T Cells
CANCER RESEARCH（2020）
Key words
Bispecific Antibodies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined